Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival

Oncotarget

Volumn 6, Issue 36, 2015, Pages 38681-38694

  Punt, Simone ^a   Corver, Willem E ^a   van der Zeeuw, Sander A J ^a   Kielbasa, Szymon M ^a   Osse, Elisabeth M ^a   Buermans, Henk P J ^a   de Kroon, Cornelis D ^a   Jordanova, Ekaterina S ^a,b   Gorter, Arko ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

B lymphocytes; Immune response; TCL1A; Tumor microenvironment; Uterine cervical cancer

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA NUCLEOTIDYLEXOTRANSFERASE; EPITHELIAL CELL ADHESION MOLECULE; T CELL LEUKEMIA LYMPHOMA 1A PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; ONCOPROTEIN; TCL1A PROTEIN, HUMAN;

ADULT; ARTICLE; B LYMPHOCYTE; CANCER PROGNOSIS; CANCER SURVIVAL; CD19 GENE; CD20 GENE; CDKN2A GENE; CELL SEPARATION; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; EMP2 GENE; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PROTEIN EXPRESSION; PTPRC GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA SEQUENCE; SURVIVAL PREDICTION; TCL1A GENE; TUMOR CELL; TUMOR VOLUME; UPREGULATION; UTERINE CERVIX CANCER; VALIDATION STUDY; WHOLE TRANSCRIPTOME ANALYSIS; AGED; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MICROENVIRONMENT; UTERINE CERVIX TUMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; SURVIVAL ANALYSIS; TUMOR MICROENVIRONMENT; UTERINE CERVICAL NEOPLASMS;

EID: 84948754020     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4526     Document Type: Article

References (47)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65: 87-108.
2. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001; 357: 539-545.
3. Ali HR, Provenzano E, Dawson SJ, Blows FM, Liu B, Shah M et al. Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients. Ann Oncol. 2014; 25: 1536-1543.
4. Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012; 12: 298-306.
5. Jordanova ES, Gorter A, Ayachi O, Prins F, Durrant LG, Kenter GG et al. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients? Clin Cancer Res. 2008; 14: 2028-2035.
6. Mantovani A. Cancer: Inflaming metastasis. Nature. 2009; 457: 36-37.
7. Zijlmans HJ, Punt S, Fleuren GJ, Trimbos JB, Kenter GG, Gorter A. Role of IL-12p40 in cervical carcinoma. Br J Cancer. 2012; 107: 1956-1962.
8. Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE et al. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer. 2008; 113: 750-757.
9. Chen MF, Chen PT, Lu MS, Lin PY, Chen WC, Lee KD. IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus. Mol Cancer. 2013; 12: 26.
10. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313: 1960-1964.
11. Stewart TJ, Abrams SI. How tumours escape mass destruction. Oncogene. 2008; 27: 5894-5903.
12. Ho DW, Yang ZF, Yi K, Lam CT, Ng MN, Yu WC et al. Gene expression profiling of liver cancer stem cells by RNA-sequencing. PLoS One. 2012; 7: e37159.
13. Van den Broeck A, Vankelecom H, Van DW, Gremeaux L, Wouters J, Allemeersch J et al. Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes. PLoS One. 2013; 8: e73968.
14. Birnie R, Bryce SD, Roome C, Dussupt V, Droop A, Lang SH et al. Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol. 2008; 9: R83.
15. Corver WE, Ter Haar NT, Fleuren GJ, Oosting J. Cervical carcinoma-associated fibroblasts are DNA diploid and do not show evidence for somatic genetic alterations. Cell Oncol (Dordr ). 2011; 34: 553-563.
16. Corver WE, Ter Haar NT. High-resolution multiparameter DNA flow cytometry for the detection and sorting of tumor and stromal subpopulations from paraffin-embedded tissues. Curr Protoc Cytom. 2011; Chapter 7: Unit 7.37.
17. Noh KH, Kim BW, Song KH, Cho H, Lee YH, Kim JH et al. Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Invest. 2012; 122: 4077-4093.
18. Takizawa J, Suzuki R, Kuroda H, Utsunomiya A, Kagami Y, Joh T et al. Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia. Jpn J Cancer Res. 1998; 89: 712-718.
19. Narducci MG, Pescarmona E, Lazzeri C, Signoretti S, Lavinia AM, Remotti D et al. Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. Cancer Res. 2000; 60: 2095-2100.
20. Virgilio L, Narducci MG, Isobe M, Billips LG, Cooper MD, Croce CM et al. Identification of the TCL1 gene involved in T-cell malignancies. Proc Natl Acad Sci U S A. 1994; 91: 12530-12534.
21. Laine J, Kunstle G, Obata T, Sha M, Noguchi M. The protooncogene TCL1 is an Akt kinase coactivator. Mol Cell. 2000; 6: 395-407.
22. Virgilio L, Lazzeri C, Bichi R, Nibu K, Narducci MG, Russo G et al. Deregulated expression of TCL1 causes T cell leukemia in mice. Proc Natl Acad Sci U S A. 1998; 95: 3885-3889.
23. Pekarsky Y, Hallas C, Croce CM. The role of TCL1 in human T-cell leukemia. Oncogene. 2001; 20: 5638-5643.
24. Hidalgo A, Baudis M, Petersen I, Arreola H, Pina P, Vazquez-Ortiz G et al. Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma. BMC Cancer. 2005; 5: 77.
25. Hoyer KK, Herling M, Bagrintseva K, Dawson DW, French SW, Renard M et al. T cell leukemia-1 modulates TCR signal strength and IFN-gamma levels through phosphatidylinositol 3-kinase and protein kinase C pathway activation. J Immunol. 2005; 175: 864-873.
26. Bergomas F, Grizzi F, Doni A, Pesce S, Laghi L, Allavena P et al. Tertiary intratumor lymphoid tissue in colo-rectal cancer. Cancers (Basel). 2011; 4: 1-10.
27. Coronella JA, Spier C, Welch M, Trevor KT, Stopeck AT, Villar H et al. Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast. J Immunol. 2002; 169: 1829-1836.
28. Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol. 2008; 26: 4410-4417.
29. Dieu-Nosjean MC, Goc J, Giraldo NA, Sautes-Fridman C, Fridman WH. Tertiary lymphoid structures in cancer and beyond. Trends Immunol. 2014; 35: 571-580.
30. Namm JP, Li Q, Lao X, Lubman DM, He J, Liu Y et al. B lymphocytes as effector cells in the immunotherapy of cancer. J Surg Oncol. 2012; 105: 431-435.
31. Bodogai M, Lee-Chang C, Wejksza K, Lai J, Merino M, Wersto RP et al. Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L. Cancer Res. 2013; 73: 2127-2138.
32. Lee-Chang C, Bodogai M, Moritoh K, Olkhanud PB, Chan AC, Croft M et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014; 124: 1450-1459.
33. Meshcheryakova A, Tamandl D, Bajna E, Stift J, Mittlboeck M, Svoboda M et al. B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer. PLoS One. 2014; 9: e99008.
34. Pelletier MP, Edwardes MD, Michel RP, Halwani F, Morin JE. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg. 2001; 44: 180-188.
35. O'Brien PM, Tsirimonaki E, Coomber DW, Millan DW, Davis JA, Campo MS. Immunoglobulin genes expressed by B-lymphocytes infiltrating cervical carcinomas show evidence of antigen-driven selection. Cancer Immunol Immunother. 2001; 50: 523-532.
36. Hilders CG, Ras L, van Eendenburg JD, Nooyen Y, Fleuren GJ. Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma. Int J Cancer. 1994; 57: 805-813.
37. Corver WE, Koopman LA, van der Aa J, Regensburg M, Fleuren GJ, Cornelisse CJ. Four-color multiparameter DNA flow cytometric method to study phenotypic intratumor heterogeneity in cervical cancer. Cytometry. 2000; 39: 96-107.
38. Corver WE, Koopman LA, Mulder A, Cornelisse CJ, Fleuren GJ. Distinction between HLA class I-positive and -negative cervical tumor subpopulations by multiparameter DNA flow cytometry. Cytometry. 2000; 41: 73-80.
39. Tighe S, Held MA. Isolation of total RNA from transgenic mouse melanoma subsets using fluorescence-activated cell sorting. Methods Mol Biol. 2010; 632: 27-44.
40. Corver WE, Cornelisse CJ. Flow cytometry of human solid tumours: clinical and research applications. Current Diagnostic Pathology. 2002; 8: 249-267.
41. Picelli S, Faridani OR, Bjorklund AK, Winberg G, Sagasser S, Sandberg R. Full-length RNA-seq from single cells using Smart-seq2. Nat Protoc. 2014; 9: 171-181.
42. R Core Team (2014). R: A language and environment for statistical computing. 2014. R Foundation for Statistical Computing, Vienna, Austria.
43. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010; 26: 139-140.
44. Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010; 11: R25.
45. Dennis G, Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003; 4: 3.
46. Punt S, Houwing-Duistermaat JJ, Schulkens IA, Thijsen VL, Osse EM, de Kroon CD et al. Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer. Mol Cancer. 2015; 14.
47. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 2012; 13: 134.